GemVax&KAEL Co.,Ltd. (KOSDAQ:082270)

South Korea flag South Korea · Delayed Price · Currency is KRW
46,600
+2,050 (4.60%)
At close: Feb 27, 2026
Market Cap1.99T +164.4%
Revenue (ttm)73.64B +17.4%
Net Income-59.72B
EPS-1,470.58
Shares Out42.78M
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume402,623
Average Volume450,241
Open46,600
Previous Close44,550
Day's Range45,900 - 48,850
52-Week Range22,500 - 72,700
Beta1.35
RSI62.36
Earnings Daten/a

About GemVax&KAEL

GemVax&KAEL Co.,Ltd engages in the manufacturing and selling of coating resins and filters for semiconductors and display production in South Korea. The company offers CA filter and gas scrubber resins for pollution control in the semiconductor and display sectors. It also engages in the research and development of anti-cancer vaccines. The company was founded in 1998 and is headquartered in Daejeon, South Korea. [Read more]

Industry Industrial - Machinery
Founded 1998
Employees 182
Stock Exchange KOSDAQ
Ticker Symbol 082270
Full Company Profile

Financial Performance

In 2024, GemVax&KAEL's revenue was 62.69 billion, a decrease of -13.18% compared to the previous year's 72.21 billion. Losses were -87.22 billion, 220.9% more than in 2023.

Financial Statements